Plain-English translation of NCT04796818 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers are testing a specialized MRI scan called intravoxel incoherent motion diffusion weighted imaging to see if it can detect early whether chemotherapy is working for people with colorectal cancer that has spread to the liver. The scan takes about 10 minutes and looks at how water moves through cancer tissue, which can reveal whether cancer cells are dying. This new approach could help doctors predict treatment success earlier than standard imaging.
Currently, doctors rely on standard imaging methods that may not detect treatment response quickly enough. This trial exists to see if the new scan can identify which patients are responding well to chemotherapy earlier, which could help doctors adjust treatment plans sooner or identify better candidates for surgery.
You likely qualify if…
You likely don't qualify if…
You would receive two specialized MRI scans as part of your routine cancer care — one within 30 days of starting chemotherapy and another after you complete 4 to 6 cycles of chemotherapy. Each scan takes about 10 minutes and involves lying still in an MRI machine while the new imaging technique captures detailed pictures of your liver tumors. No additional injections or procedures beyond what's typically done with standard MRI are required.
AI-generated summary from trial data · Jul 6, 2026 · Not medical advice
United States